# Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma

> **NCT02946138** · PHASE2 · WITHDRAWN · sponsor: **Shanghai Proton and Heavy Ion Center**

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** carbon-ion radiotherapy

## Key facts

- **NCT ID:** NCT02946138
- **Lead sponsor:** Shanghai Proton and Heavy Ion Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-10
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** enrollment was too slow
- **Last updated:** 2019-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02946138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02946138, "Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02946138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*